Nasdaq:US$15.81 (+0.12) | HKEX:HK$24.65 (-0.55) | AIM:£2.30 (+0.09)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF